Angiotensin III (human, mouse)Cat. No. 1564 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
Biological Activity
Endogenous vasoconstrictor peptide, formed from the conversion of angiotensin II in vivo. Acts at both AT1 and AT2 receptors and increases vasopressin (anti-diuretic hormone) release and blood pressure.Certificate of Analysis / Safety Data Sheet
References
Devynck et al (1977) Specific receptors for des-Asp1-angiotensin II ("angiotensin III") in rat adrenals. Proc.Natl.Acad.Sci.U.S.A. 74 4029. PMID: 198814.
Luoh and Chan (1998) Participation of AT1 and AT2 receptor subtypes in the tonic inhibitory modulation of baroreceptor reflex response by endogenous angiotensins at the nucleus tractus solitarii in the rat. Brain Res. 782 73. PMID: 9519251.
Reaux et al (2001) Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol.Metab. 12 157. PMID: 11295571.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: Angiotensin III (human, mouse), supplier, Vasoconstrictor, peptide, AT, Receptors, Non-Selective, Angiotensin, agonists, AngiotensinIII, (human, mouse)
Quick Order
Find multiple products by catalog number
New Products in this Area
AT1 receptor antagonist
Candesartan cilexetilProdrug of candesartan, an AT1 receptor antagonist
Tocris Events
Meet your representative
The Role of Cytokines and Signaling in Inflammation
October 15, 2013
Bonn, Germany





